Molecular Partners AG
MOLN
$3.80
-$0.09-2.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -2.13% | 23.24% | |||
| Gross Profit | 2.13% | -23.24% | |||
| SG&A Expenses | 3.12% | -22.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.75% | 6.59% | |||
| Operating Income | 0.75% | -6.59% | |||
| Income Before Tax | -32.53% | -45.90% | |||
| Income Tax Expenses | -- | -195.65% | |||
| Earnings from Continuing Operations | -32.55% | -45.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.55% | -45.86% | |||
| EBIT | 0.75% | -6.59% | |||
| EBITDA | 1.11% | -4.69% | |||
| EPS Basic | -30.72% | -45.88% | |||
| Normalized Basic EPS | -13.95% | -45.92% | |||
| EPS Diluted | -30.72% | -45.00% | |||
| Normalized Diluted EPS | -13.95% | -45.92% | |||
| Average Basic Shares Outstanding | 1.40% | -0.02% | |||
| Average Diluted Shares Outstanding | 1.40% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||